IL23a silencing occurs in ductal carcinoma in situ in the breast.

We found by comparing total transcription in the normal breast and in ductal carcinoma in situ silencing of the cytokine IL-23a during transformation of the breast in vivo.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-10-29
DOI
https://doi.org/10.5281/zenodo.23771479
Primary Topic
Breast Cancer Treatment Studies
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

IL23a silencing occurs in ductal carcinoma in situ in the breast.

Shahan Mamoor
1 links
Zenodo (CERN European Organization for Nuclear Research)
Breast Cancer Treatment Studies
preprint

IL23a silencing occurs in ductal carcinoma in situ in the breast.

Shahan Mamoor
preprint en

Abstract

We found by comparing total transcription in the normal breast and in ductal carcinoma in situ silencing of the cytokine IL-23a during transformation of the breast in vivo.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Breast Cancer Treatment Studies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
IL23a silencing occurs in ductal carcinoma in situ in the breast. — Shahan Mamoor · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS